Ronak Haj Ersan

Ronak Haj Ersan

Auto-generated profile, based on publicly available information

Ronak Haj Ersan

Cihan University-Duhok

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2022 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
GOGozde Yalcin Ozkat
Gozde Yalcin Ozkat
RERonak H. Ersan
Ronak H. Ersan
MUMahmut Ulger
Mahmut Ulger
SUSeda T. Ulger
Seda T. Ulger
SBSerdar Burmaoglu
Serdar Burmaoglu
OAOztekin Algul
Oztekin Algul
The increase in the drug-resistant strains of Mycobacterium tuberculosis has led researchers to new drug targets. The development of new compounds that have effective inhibitory properties with the selective vital structure of Mycobacterium tuberculosis is required in new scientific approaches. The most important of these approaches is the development of inhibitor molecules for Mycobacterium cell wall targets. In this study, first of all, the antitubercular activity of 23 benzimidazole derivatives was experimentally determined. And then molecular docking studies were carried out with 4 different targets: Arabinosyltransferase C (EmbC), Filamentous Temperature Sensitive Mutant Z (FtsZ), Protein Tyrosine Phosphatase B (PtpB), and Decaprenylphosphoryl-β-D-ribose-2′-oxidase (DprE1). It has been determined that benzimidazole derivatives show activity through the DprE1 enzyme. It is known that DprE1, which has an important role in the synthesis of the cell envelope from Arabinogalactan, is also effective in the formation of drug resistance. Due to this feature, the DprE1 enzyme has become an important target for drug development studies. Also, it was chosen as a target for this study. This study aims to identify molecules that inhibit DprE1 for the development of more potent and selective antitubercular drugs. For this purpose, molecular docking studies by AutoDock Vina, and CDOCKER and molecular dynamics (MD) simulations and in silico ADME/Tox analysis were implemented for 23 molecules. The molecules exhibited binding affinity values of less than −8.0 kcal/mol. After determining the compound’s anti-TB activities by a screening test, the best-docked results were detected using compounds 20, 21, and 30. It was found that 21, was the best molecule with its binding affinity value, which was supported by MD simulations and in silico ADME modeling results. Communicated by Ramaswamy H. Sarma.

30 November 2020 in Polycyclic Aromatic Compounds
Verified
Journal Article
Closed access
RERonak Haj Ersan
Ronak Haj Ersan
MAMehmet Abdullah Alagöz
Mehmet Abdullah Alagöz
ADAylin Dogen
Aylin Dogen
NDNizami Duran
Nizami Duran
SBSerdar Burmaoglu
Serdar Burmaoglu
OAOztekin Algul
Oztekin Algul
Four series of bisbenzoxazole derivatives were designed, synthesized, and screened for antiproliferative and antimicrobial activities. Generally, all synthesized bisbenzoxazoles (9–24) displayed significant antiproliferative activity; these effects were shown to be related to oxazole rings and substituents in bisbenzoxazole compounds. Especially, the series bearing chloro-substituent (9–12) exhibited better antiproliferative activity with higher selectivity than the other series (13–24); the IC50 values were observed in the range of 0.045–0.342 µM. Interestingly, only the compound with a nitro substituent (22) showed maximum potency with an IC50 value of 0.011 µM, which is two-fold more active than the standard drug methotrexate, with moderate selectivity. The compounds bearing fluoro-substituent (14–16) were found to exhibit potent antibacterial activity against the Gram-positive Enterococcus faecalis, with a MIC value of 62.5 μg/mL, and moderate activity against Gram-negative bacteria and fungi. Only the compound 23 showed potent activity against Escherichia coli, with a MIC value of 62.5 μg/mL. In order to better evaluate the activity results, crystal structures of five different proteins Human Anaplastic Lymphoma Kinase (PDB ID: 2XP2), CYP2C8dH complexed (PDB ID: 2NNI), factor-human kinase-β enzyme IKK-β enzyme (PDB ID: 4KIK), a tubulin heterodimer complex containing α and β sub-units (PDB ID: 1Z2B) and penicillin-binding protein 4 (PBP4) from Enterococcus faecalis (PDB ID: 6MKI) were used in the docking study to examine antiproliferative and antimicrobial activity. Finally, an ADMET screening test was applied to determine the drug-like, toxicological, and optimum physicochemical properties for all of the synthesized compounds. The strategy applied in this research may act as a perspective for the rational design of potential anticancer drugs. Graphical Abstract

11 June 2019 in TURKISH JOURNAL OF CHEMISTRY
Verified
Journal Article
Open access
FAFurkan Ayaz
Furkan Ayaz
RKRusmeenee Kheeree
Rusmeenee Kheeree
QIQadar Ahmed Isse
Qadar Ahmed Isse
RERonak Haj Ersan
Ronak Haj Ersan
ÖAÖztekin Algül
Öztekin Algül

31 July 2019 in Eskişehir Teknik Üniversitesi Bilim ve Teknoloji Dergisi - C Yaşam Bilimleri ve Biyoteknoloji
Verified
Journal Article
Closed access
FAFurkan Ayaz
Furkan Ayaz
QIQadar Ahmed Isse
Qadar Ahmed Isse
RKRusmeenee Kheeree
Rusmeenee Kheeree
RERonak Haj Ersan
Ronak Haj Ersan
OAOztekin Algul
Oztekin Algul

28 June 2022 in Bioorganic and Medicinal Chemistry Reports
Verified
Journal Article
Closed access
RERonak Haj Ersan
Ronak Haj Ersan
KJKajeen Jasim
Kajeen Jasim
HSHaytham Sabeeh
Haytham Sabeeh
KAKnar Ahmed
Knar Ahmed
DADarya Abdulsatar
Darya Abdulsatar
SAShana Ali
Shana Ali
Compounds bearing naphthalene and benzimidazole pharmacophores have been reported to possess excellent anticancer activity. In view of this, we designed, synthesized and characterized a series of naphthalene substituted benzimidazole derivatives (11–19), and further evaluated them for antiproliferative activities by employing MTT method. Among the nine investigated molecules, compounds (11 and 13) showed good antiproliferation of the tested cancer cell lines with IC50 values ranging from 0.078 to 0.625 µM. In addition, compound (18) exhibited selective cytotoxicity against HepG2 cell lines with high safety to normal cell (HEK293). Furthermore, cytotoxicity studies of these compounds against normal Human embryonic kidney cells (HEK293) revealed that the target molecules were less selective against HEK293 as compared to methotrexate (positive control). The high potency and selective cytotoxicity suggested that compound 18 could be a starting point for further optimization to develop novel antitumor agents towards liver cancer.

7 June 2021 in Bioorganic and Medicinal Chemistry Reports
Verified
Journal Article
Closed access
RERonak Haj Ersan
Ronak Haj Ersan
NDNizami Duran
Nizami Duran
In the present work, a series of fluoro-substituted benzimidazole derivatives were designed and synthesized as antiproliferative agents. The antiproliferative activity of these compounds was investigated using MTT assay. Fluoro-substituted benzimidazole derivatives showed significant antiproliferative activity against all the tested cancer cell lines. All the derivatives were found to be less toxic as compared to methotrexate (positive control) in human cells, indicating selective and efficient antiproliferative activity of these benzimidazole derivatives. These findings suggest that compounds ORT14 and ORT15 among this series are most effective and have potential for detailed investigations.